LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
1 mg |
33604-1 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
10 mg |
33604-10 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
25 mg |
33604-25 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
5 mg |
33604-5 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
1 mg |
25978-1 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
10 mg |
25978-10 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
5 mg |
25978-5 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
50 mg |
25978-50 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
1 mg |
16712-1 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
10 mg |
16712-10 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
5 mg |
16712-5 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
50 mg |
16712-50 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
1 mg |
26791-1 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
10 mg |
26791-10 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
25 mg |
26791-25 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
5 mg |
26791-5 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
1 mg |
21560-1 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
10 mg |
21560-10 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
25 mg |
21560-25 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
5 mg |
21560-5 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
1 mg |
34880-1 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
10 mg |
34880-10 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
25 mg |
34880-25 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
5 mg |
34880-5 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
1 mg |
20843-1 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
10 mg |
20843-10 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
25 mg |
20843-25 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
5 mg |
20843-5 |
More Info
|
LY2886721 |
Selective inhibitor of BACE (IC50 = 20 nM for recombinant hBACE1) |
1 mg |
21599-1 |
More Info
|
LY2886721 |
Selective inhibitor of BACE (IC50 = 20 nM for recombinant hBACE1) |
10 mg |
21599-10 |
More Info
|
LY2886721 |
Selective inhibitor of BACE (IC50 = 20 nM for recombinant hBACE1) |
25 mg |
21599-25 |
More Info
|
LY2886721 |
Selective inhibitor of BACE (IC50 = 20 nM for recombinant hBACE1) |
5 mg |
21599-5 |
More Info
|
LY293111 |
A potent antagonist of the LTB4 receptor, BLT1, that inhibits the specific… |
1 mg |
10009768-1 |
More Info
|
LY293111 |
A potent antagonist of the LTB4 receptor, BLT1, that inhibits the specific… |
10 mg |
10009768-10 |
More Info
|
LY293111 |
A potent antagonist of the LTB4 receptor, BLT1, that inhibits the specific… |
5 mg |
10009768-5 |
More Info
|
LY293111 |
A potent antagonist of the LTB4 receptor, BLT1, that inhibits the specific… |
500 µg |
10009768-500 |
More Info
|
LY294002 |
A selective PI3K inhibitor with an IC50 value of 1.4 µM |
10 mg |
70920-10 |
More Info
|
LY294002 |
A selective PI3K inhibitor with an IC50 value of 1.4 µM |
25 mg |
70920-25 |
More Info
|
LY294002 |
A selective PI3K inhibitor with an IC50 value of 1.4 µM |
5 mg |
70920-5 |
More Info
|
LY294002 |
A selective PI3K inhibitor with an IC50 value of 1.4 µM |
50 mg |
70920-50 |
More Info
|
LY2940680 |
A Smo antagonist; inhibits [35S]GTPγS binding in CHO cells expressin… |
1 mg |
16264-1 |
More Info
|
LY2940680 |
A Smo antagonist; inhibits [35S]GTPγS binding in CHO cells expressin… |
10 mg |
16264-10 |
More Info
|
LY2940680 |
A Smo antagonist; inhibits [35S]GTPγS binding in CHO cells expressin… |
5 mg |
16264-5 |
More Info
|
LY2955303 |
A potent RARγ antagonist (Ki = 1.1 nM); selective for RARγ ove… |
1 mg |
25833-1 |
More Info
|
LY2955303 |
A potent RARγ antagonist (Ki = 1.1 nM); selective for RARγ ove… |
10 mg |
25833-10 |
More Info
|
LY2955303 |
A potent RARγ antagonist (Ki = 1.1 nM); selective for RARγ ove… |
25 mg |
25833-25 |
More Info
|
LY2955303 |
A potent RARγ antagonist (Ki = 1.1 nM); selective for RARγ ove… |
5 mg |
25833-5 |
More Info
|
LY3000328 |
A potent cathepsin S inhibitor (IC50 = 7.7 nM for the human enzyme); selec… |
1 mg |
29729-1 |
More Info
|
LY3000328 |
A potent cathepsin S inhibitor (IC50 = 7.7 nM for the human enzyme); selec… |
10 mg |
29729-10 |
More Info
|
LY3000328 |
A potent cathepsin S inhibitor (IC50 = 7.7 nM for the human enzyme); selec… |
5 mg |
29729-5 |
More Info
|